Abstract
Background
During the last 20 years the prevalence of both gastroesophageal reflux disease (GERD) and obesity has been increasing in the United States. The pathophysiology of GERD is multifactorial and its relationship with obesity is still not well understood.
Aim
To evaluate the association between BMI and GERD as detected by multichannel intraluminal impedance-pH (MII-pH) monitoring.
Methods
Retrospective review of 122 consecutive MII-pH studies of adult patients while on PPI therapy. Patients were divided into normal (BMI < 25), overweight (BMI ≥ 25 and <30) and obese (BMI ≥ 30). Reflux episodes were classified as acid reflux (AR), nonacid reflux (NAR), and total number of reflux episodes, as detected by MII-pH. We evaluated the symptoms associated with reflux by using the symptom index (SI). We also assessed the number of reflux episodes during recumbency and compared them in the different BMI groups.
Results
The total number of reflux episodes and NAR episodes increased significantly as BMI increased. There was no significant difference between groups in AR. Similarly, during recumbency, total number of reflux episodes increased significantly when BMI increased. For symptoms associated with reflux, SI was more likely to be positive in the obese group.
Conclusions
This study shows a clear association between increased reflux as detected by MII-pH and higher BMI. Obesity not only increases the likelihood of reflux events, as shown in previous studies, but also makes it more likely that symptoms reported during MII-pH studies are actually due to MII detected reflux.
Similar content being viewed by others
References
Mokdad AH, Serdula MK, Dietz WH, et al. The spread of the obesity epidemic in the United States, 1991–1998. JAMA. 1999;282:1519–1522.
Flegal KM, Carroll MD, Ogden CL, et al. Prevalence and trends in obesity among US adults, 1999–2000. JAMA. 2002;288:1723–1727.
Ogden CL, Carroll MD, McDowell, et al. Obesity among adults in the United States—no statistically significant change since 2003–2004. NCHS Data Brief. 2007;1:1–8.
Blumberg SJ, Luke JV, Davidson G, et al. Wireless substitution: state-level estimates from the National Health Interview Survey, January-December 2007. Natl Health Stat Report. 2009;11:16.
El-Serag HB, Petersen NJ, Carter J, et al. Gastroesophageal reflux among different racial groups in the United States. Gastroenterology. 2004;126:1692–1699.
Lambert R. In search of reliability in the description of gastroesophageal reflux disease (GERD). Esophagus. 2008;5:5–9.
El Serag HB. The association between obesity and GERD: a review of the epidemiological evidence. Dig Dis Sci. 2008;53:2307–2312.
Crowell MD, Bradley A, Hansel S, et al. Obesity is associated with increased 48-h esophageal acid exposure in patients with symptomatic gastroesophageal reflux. Am J Gastroenterol. 2009;104:553–559.
Ayazi S, Hagen JA, Chan LS, et al. Obesity and gastroesophageal reflux: quantifying the association between body mass index, esophageal acid exposure, and lower esophageal sphincter status in a large series of patients with reflux symptoms. J Gastrointest Surg. 2009;13:1440–1447.
Sifrim D, Castell D, Dent J, et al. Gastro-oesophageal reflux monitoring: review and consensus report on detection and definitions of acid, non-acid, and gas reflux. Gut. 2004;53:1024–1031.
Hirano I, Richter JE, et al. ACG practice guidelines: esophageal reflux testing. Am J Gastroenterol. 2007;102:668–685.
National Institutes of Health. Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults—the evidence report. Obes Res. 1998;6:51S–209S.
Wiener GJ, Richter JE, Copper JB, et al. The symptom index: a clinically important parameter of ambulatory 24-hour esophageal pH monitoring. Am J Gastroenterol. 1988;83:358–361.
Singh S, Richter JE, Bradley LA, et al. The symptom index. Differential usefulness in suspected acid-related complaints of heartburn and chest pain. Dig Dis Sci. 1993;38:1402–1408.
Mainie I, Tutuian R, Shay S, et al. Acid and non-acid reflux in patients with persistent symptoms despite acid suppressive therapy: a multicenter study using combined ambulatory impedance-pH monitoring. Gut. 2006;55:1398–1402.
Kuo B, Castell DO. Optimal dosing of omeprazole 40 mg daily: effects on gastric and esophageal pH and serum gastrin in healthy controls. Am J Gastroenterol. 1996;91:1532–1538.
World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO convention, Geneva, 1999. World Health Organ Tech Rep Ser. 2000;894:1–253.
Connor J, Richter J. Increasing yield also increases false positives and best serves to exclude GERD. Am J Gastroenterol. 2006;101:460–463.
Pandolfino J. The relationship between obesity and GERD: “big or overblown”. Am J Gastroenterol. 2008;103:1355–1357.
Wu JC, Mui LM, Cheung CM, et al. Obesity is associated with increased transient lower esophageal sphincter relaxation. Gastroenterology. 2007;132:883–889.
Pandolfino JE, El Serag HB, Zhang Q, et al. Obesity: a challenge to esophagogastric junction integrity. Gastroenterology. 2006;130:639–649.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hajar, N., Castell, D.O., Ghomrawi, H. et al. Impedance pH Confirms the Relationship Between GERD and BMI. Dig Dis Sci 57, 1875–1879 (2012). https://doi.org/10.1007/s10620-012-2131-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10620-012-2131-6